Fifty-four patients (46 Toulouse, 8 Lyon) were implanted with 173 hybrid electrodes. Recordings were acquired using Blackrock or Neuralynx systems at 2,048 Hz (macro) and >30,000 Hz (micro). FRs were automatically detected during one hour of awake recording per patient using Halyzia software. Safety was assessed through adverse event reporting (ANSM, article R.1123-39 §4) and postoperative MRI. Recording feasibility was evaluated from hourly FR rates at both scales, while biomarker performance was quantified by sensitivity, specificity, and predictive values. All recording contacts were classified based on their localization within the epileptogenic, irritative, or propagation zones.